Skip to main content
. Author manuscript; available in PMC: 2020 Sep 8.
Published in final edited form as: J Vasc Surg. 2019 Mar 11;70(3):724–731.e1. doi: 10.1016/j.jvs.2018.12.031

Table III.

First-time non-fatal CV events in AD/IMH/PAU patients versus population referents (adjusted for the Charlson Comorbidity Index). Number at risk includes only subjects without a CV event prior to AD/IMH/PAU diagnosis/the index date.

All CV events Excluding acute CV events*

AD/IMH/PAU No. at risk/events Referents No. at risk/events HR (95% CI) p AD/IMH/PAU No. at risk/events Referents No. at risk/events HR (95% CI) p

Any CV event 100 / 36 252 / 43 3.0 (1.9 – 4.8) <.001 80 / 27 206 / 33 2.6 (1.5 – 4.4) <.001
MI 120 / 7 343 / 14 1.6 (0.6 – 4.2) .342 103 / 4 295 / 10 1.2 (0.3 – 4.0) .811
HF 117 / 32 328 / 44 2.7 (1.7 – 4.3) <.001 98 / 27 277 / 34 2.5 (1.5 – 4.3) <.001
Stroke 122 / 9 340 / 18 2.3 (0.99 – 5.2) .051 105 / 5 294 / 14 1.5 (0.5 – 4.3) .465
*

including deaths >14 days of diagnosis only